Evidence map›Paper›PMID 41516425›Full record

ArticleInternational journal of molecular sciences2026

Differential Glycosylation Patterns in Parkinson's Disease: Emphasis on Male-Specific Changes Identified via HILIC-LC-MS.

Béla Demeter, Adriána Kutás, Béla Viskolcz, Csaba Oláh, Edina Petercsák, Attila Garami, Csaba Váradi

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Béla DemeterInstitute of Chemistry, Faculty of Materials Science and Chemical Engineering, University of Miskolc, 3515 Miskolc, Hungary.
Adriána KutásInstitute of Chemistry, Faculty of Materials Science and Chemical Engineering, University of Miskolc, 3515 Miskolc, Hungary.
Béla ViskolczInstitute of Chemistry, Faculty of Materials Science and Chemical Engineering, University of Miskolc, 3515 Miskolc, Hungary.ORCID 0000-0002-0777-9569
Csaba OláhBorsod-Abaúj-Zemplén County Center Hospital and University Teaching Hospital, Department of Neurosurgery, 3526 Miskolc, Hungary.ORCID 0000-0001-9598-9322
Edina PetercsákBorsod-Abaúj-Zemplén County Center Hospital and University Teaching Hospital, Department of Neurosurgery, 3526 Miskolc, Hungary.
Attila GaramiInstitute of Energy, Ceramic and Polymer Technology, University of Miskolc, 3515 Miskolc, Hungary.
Csaba VáradiInstitute of Chemistry, Faculty of Materials Science and Chemical Engineering, University of Miskolc, 3515 Miskolc, Hungary.ORCID 0000-0002-2672-095X

Funding

University of Miskolc ME-TKTP-2025-083
6 · The paper itself

Abstract

Parkinson's disease (PD) is a progressive neurodegenerative disorder primarily characterized by the degeneration of dopaminergic neurons, leading to significant motor and non-motor symptoms. This study investigates glycosylation patterns with a significant emphasis on male Parkinson's Disease (PD) patients, revealing unique alterations distinguishing PD from healthy states, utilizing high-performance liquid chromatography coupled with mass spectrometry (HILIC-LC-MS). Findings reveal significantly altered serum N-glycosylation profiles between male and female patients, with increased levels of high-mannose glycans and reduced mono-sialylated glycans in male patients. ROC curve analysis indicates that these glycan changes are the most important features for distinguishing PD from healthy states, with AUC values of 0.71 for M5 and 0.85 for M6. This study underscores the critical role of glycosylation in the pathophysiology of Parkinson's disease and highlights its potential in early detection and monitoring of disease progression.

Indexed as

Parkinson DiseasePolysaccharidesChromatography, High Pressure LiquidGlycosylationHumansLiquid Chromatography-Mass SpectrometryMalePolysaccharidesglycosylationliquid chromatographyParkinson’s disease

Identifiers

PMID41516425
PMCPMC12787113

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.